The Institute for Data Science in Oncology at MD Anderson appointed Iakovos Toumazis, Ph.D., to lead its work on data science innovations in cancer prevention and decision support. Toumazis brings combined expertise in operations research and cancer prevention, and MD Anderson framed the hire as central to scaling predictive analytics for population‑level interventions. The appointment signals continued institutional investment in computational approaches that integrate epidemiology, genomics, and health‑system operations. For biotechs and diagnostics firms, IDSO’s leadership choices influence collaborative priorities for model validation, real‑world evidence generation, and precompetitive data sharing.